NCT00004422

Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 174 (planned)
• Sponsor: IWK Health Centre · Academic / Other
• Sex: All
• Age: 5 Years
• Healthy volunteers: Not accepted

Summary

OBJECTIVES: Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.

Detailed description

PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline). Patients are followed every 2 weeks for up to 6 months. Completion date provided represents the completion date of the grant per OOPD records

Conditions

• Pertussis
• Whooping Cough

Interventions

Type	Name	Description
DRUG	immune globulin

Timeline

• Start date: 1997-08-01
• Completion: 2002-09-01
• First posted: 1999-10-19
• Last updated: 2015-03-25